GATINEAU, Quebec, Oct. 23, 2019 /PRNewswire/ — Digital medical technologies are driving improvements in chronic disease management, improved diagnosis, and personalized treatments as a result of access to quality data, interoperability, and care delivery. KPMG estimates that the medical device industry’s global annual sales will increase more than 5% a year to reach nearly $800 billion by 2030. Medical device companies will see continue to realize growth via product and software innovation.
“Healthcare is transforming. The way in which health conditions are treated, managed, prevented is evolving toward a patient-centric approach. I am extremely proud that Macadamian enables the innovators and disruptors in MedTech to break into new frontiers, but more so being able to help improve people’s lives.” Frederic Boulanger, CEO Macadamian Technologies
Macadamian is partnered with Healthcare Providers, Medical Research Institutes and MedTech vendors alike to develop disruptive healthcare software solutions to improve patient outcomes. Examples of Healthcare projects include:
“Having partnered with Macadamian at Medtronic for over 3 years, I did not hesitate in reaching out once again for my latest venture. I have full confidence in the depth of their expertise in healthcare to help us bring to market a disruptive Health IT solution. It is exciting to be part of Macadamian’s growth.” Paul Cox, Co-founder, Magic Medical Solutions.
December 3, 2019, at RSNA in Chicago, Macadamian will be launching a new digital health platform as a service, Macadamian HealthConnectTM. Using the HealthConnect platform as a basis for custom healthcare software development allows Macadamian to focus immediately on developing innovative functionality for clients. For Macadamian’s MedTech clients, this means reduced development costs and much faster time to market than starting application development from scratch.
Photo(s):
https://www.prlog.org/12794218
Press release distributed by PRLog
View original content:http://www.prnewswire.com/news-releases/macadamian-technologies-witnesses-300-growth-in-healthcare-revenues-becoming-an-established-software-development-partner-of-choice-in-medtech-300943638.html
SOURCE Macadamian Technologies
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…